1.98
price up icon5.88%   0.11
pre-market  시장 영업 전:  1.90   -0.08   -4.04%
loading
전일 마감가:
$1.87
열려 있는:
$2.02
하루 거래량:
470.34K
Relative Volume:
0.28
시가총액:
$4.47M
수익:
-
순이익/손실:
$-6.91M
주가수익비율:
-0.6074
EPS:
-3.26
순현금흐름:
$-6.14M
1주 성능:
-15.02%
1개월 성능:
+7.03%
6개월 성능:
-32.44%
1년 성능:
-43.74%
1일 변동 폭
Value
$1.9301
$2.07
1주일 범위
Value
$1.61
$2.30
52주 변동 폭
Value
$1.15
$23.80

Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile

Name
명칭
Galmed Pharmaceuticals Ltd
Name
전화
-
Name
주소
-
Name
직원
6
Name
트위터
@GalmedPharma
Name
다음 수익 날짜
2025-03-26
Name
최신 SEC 제출 서류
Name
GLMD's Discussions on Twitter

GLMD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GLMD
Galmed Pharmaceuticals Ltd
1.98 4.22M 0 -6.91M -6.14M -3.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-05-22 다운그레이드 B. Riley FBR Buy → Neutral
2020-02-04 개시 Craig Hallum Buy
2020-01-30 재개 Cantor Fitzgerald Overweight
2019-12-02 개시 Canaccord Genuity Buy
2018-12-12 개시 B. Riley FBR Buy
2018-08-02 재확인 Maxim Group Buy
2018-07-13 개시 Stifel Buy
2018-07-12 개시 Cantor Fitzgerald Overweight
2018-06-12 재확인 H.C. Wainwright Buy
2018-03-15 업그레이드 Maxim Group Hold → Buy
2018-02-14 다운그레이드 Maxim Group Buy → Hold
2018-02-12 재확인 H.C. Wainwright Buy
2017-11-15 개시 ROTH Capital Buy
2017-08-08 재확인 H.C. Wainwright Buy
2017-07-31 재확인 Maxim Group Buy
2016-08-01 재확인 Maxim Group Buy
2016-07-06 재개 ROTH Capital Buy
2016-03-28 재개 H.C. Wainwright Buy
2015-06-23 개시 H.C. Wainwright Buy
2015-05-06 개시 Sun Trust Rbsn Humphrey Buy
모두보기

Galmed Pharmaceuticals Ltd 주식(GLMD)의 최신 뉴스

pulisher
Jul 24, 2025

Galmed Pharmaceuticals to Hold Special Meeting on Share Capital Increase - TipRanks

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Galmed Pharmaceuticals Ltd. stockFree Stock Market Beginners Guide - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Galmed Pharmaceuticals Ltd. Stock Analysis and ForecastMarket-crushing stock picks - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Galmed Pharmaceuticals Ltd. stock priceMassive stock growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Galmed Pharmaceuticals Ltd. a good long term investmentTurbocharged investment results - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

The Role of News and Events in Galmed Pharmaceuticals Ltd Inc. (GLMD) Price Performance - investchronicle.com

Jul 21, 2025
pulisher
Jul 20, 2025

Why India’s Pharmaceutical Stocks Are on the Rise High Accuracy Trade SignalsRapid market gains - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

Solara Active Pharma Sciences Limited (SOLARAPP)’s Trend in 2025Free Stock Market Forecast Reports - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

PLAB Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Galmed Pharmaceuticals Ltd. stock price move sharplyFree Insider Trading Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Galmed Pharmaceuticals Ltd. stock attracts strong analyst attentionSafe and Scalable Investment Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Galmed Pharmaceuticals Ltd. stock performs during market volatilitySteady Profit Stock Forecasts - Newser

Jul 15, 2025
pulisher
Jun 03, 2025

Galmed Pharmaceuticals Ltd. to Host Earnings Call - ACCESS Newswire

Jun 03, 2025
pulisher
May 27, 2025

Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar Expansion Potential Beyond Nash - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

Galmed Pharmaceuticals Unveils Biomarker Signature for Aramchol, Expanding Market Potential - TipRanks

May 27, 2025
pulisher
May 27, 2025

Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar Expansion Potential Beyond NASH - Longview News-Journal

May 27, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades Galmed Pharmaceuticals (NASDAQ:GLMD) to Sell - Defense World

May 24, 2025
pulisher
May 23, 2025

Galmed Pharmaceuticals: Q1 Earnings Snapshot - New Haven Register

May 23, 2025
pulisher
May 22, 2025

Galmed Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Galmed Pharmaceuticals Reports Q1 2025 Financial Results and Advances in Oncology - TipRanks

May 22, 2025
pulisher
May 22, 2025

Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

May 22, 2025
pulisher
May 15, 2025

Galmed Pharmaceuticals (NASDAQ:GLMD) Coverage Initiated at StockNews.com - Defense World

May 15, 2025
pulisher
May 14, 2025

Galmed Pharmaceuticals Unveils Promising Aramchol Results in PSC Models - TipRanks

May 14, 2025
pulisher
May 14, 2025

Galmed (GLMD) Announces Promising Pre-Clinical Results for Aramc - GuruFocus

May 14, 2025

Galmed Pharmaceuticals Ltd (GLMD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
자본화:     |  볼륨(24시간):